Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence and Safety Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions: a Randomized, Open-label, Single-dose, Crossover Study

NCT07558967 is registered in ClinicalTrials.gov with Haisco Pharmaceutical Group Co., Ltd. as lead sponsor.

NCT NCT07558967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07558967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence and Safety Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions: a Randomized, Open-label, Single-dose, Crossover Study
Lead sponsor
Haisco Pharmaceutical Group Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
June 20, 2017
Completion date
November 20, 2017
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy